Evidence map›Paper›PMID 21841848›Full record

ArticleCarbohydrate polymers2011

Controlled Photochemical Depolymerization of K5 Heparosan, a Bioengineered Heparin Precursor.

Kyohei Higashi, Mellisa Ly, Zhenyu Wang, Sayaka Masuko, Ujjwal Bhaskar, Eric Sterner, Fuming Zhang, Toshihiko Toida, Jonathan S Dordick, Robert J Linhardt

Open access · greenAbstract read
In one paragraph

Article in Carbohydrate polymers, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Engineered heparins as new anticoagulant drugs.Bioengineering & translational medicine · 2017
    Review
  3. Article
  4. Bioengineered heparins and heparan sulfates.Advanced drug delivery reviews · 2016
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Kyohei HigashiGraduate School of Pharmaceutical Sciences Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8675, Japan.
Mellisa Ly
Zhenyu Wang
Sayaka Masuko
Ujjwal Bhaskar
Eric Sterner
Fuming Zhang
Toshihiko Toida
Jonathan S Dordick
Robert J Linhardt
Rensselaer Polytechnic Institute · USChiba University · JP

Funding

Development of a Bioengineered Heparin from a Non-Animal SourceR01HL096972 · NHLBI · RENSSELAER POLYTECHNIC INSTITUTE · PI DORDICK, JONATHAN S., LINHARDT, ROBERT J · 2009 to 2013
$3.9M
SEQUENCING THE POLYSACCHARIDE COMPONENT OF PROTEOGLYCANSR01GM038060 · NIGMS · UNIVERSITY OF IOWA · PI LINHARDT, ROBERT J · 1988 to 2012
$2.8M
Characterization of Anticoagulant Heparin and Related PolysaccharidesRC2HL101721 · NHLBI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LINHARDT, ROBERT J, SASISEKHARAN, RAM · 2009 to 2010
$1.3M
NHLBI NIH HHS R01 HL096972NHLBI NIH HHS RC2 HL101721NIGMS NIH HHS R01 GM038060
6 · The paper itself

Abstract

Heparosan is a polysaccharide, which serves as the critical precursor in heparin biosynthesis and chemoenzymatic synthesis of bioengineered heparin. Because the molecular weight of microbial heparosan is considerably larger than heparin, the controlled depolymerization of microbial heparosan is necessary prior to its conversion to bioengineered heparin. We have previously reported that other acidic polysaccharides could be partially depolymerized with maintenance of their internal structure using a titanium dioxide-catalyzed photochemical reaction. This photolytic process is characterized by the generation of reactive oxygen species that oxidize individual saccharide residues within the polysaccharide chain. Using a similar approach, a microbial heparosan from Escherichia coli K5 of molecular weight >15,000 was depolymerized to a heparosan of molecular weight 8,000. The (1)H-NMR spectra obtained showed that the photolyzed heparosan maintained the same structure as the starting heparosan. The polysaccharide chains of the photochemically depolymerized heparosan were also characterized by electrospray ionization-Fourier-transform mass spectrometry. While the chain of K5 heparosan starting material contained primarily an even number of saccharide residues, as a result of coliphage K5 lyase processing, both odd and even chain numbers were detected in the photochemically-depolymerized heparosan. These results suggest that the photochemical depolymerization of heparosan was a random process that can take place at either the glucuronic acid or the N-acetylglucosamine residue within the heparosan polysaccharide.

Identifiers

PMID21841848
PMCPMC3153860
OpenAlexW2152898843

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.